These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29402299)

  • 41. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
    Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
    Mittra I; Redkar AA; Badwe RA
    J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study.
    López C; Callau C; Bosch R; Korzynska A; Jaén J; García-Rojo M; Bueno G; Salvadó MT; Álvaro T; Oños M; Fernández-Carrobles Mdel M; Llobera M; Baucells J; Orero G; Lejeune M
    BMJ Open; 2014 Aug; 4(8):e005643. PubMed ID: 25091015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The analysis of prognostic factors in stage III-B non-inflammatory breast cancer.
    Yildirim E; Semerci E; Berberoğlu U
    Eur J Surg Oncol; 2000 Feb; 26(1):34-8. PubMed ID: 10718177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological assessment of the prognostic factors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Mari S; Alhava E; Syrjänen K
    Oncology; 1992; 49(1):1-8. PubMed ID: 1542486
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
    Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
    van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of prognostic parameters in patients with breast cancer of size smaller than or equal to 2 cm].
    Xue C; Fu F; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):245-9. PubMed ID: 25975906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Grading and prognosis of invasive ductal mammary carcinoma by nuclear image analysis in tissue sections.
    Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
    Pathol Res Pract; 1989 Nov; 185(5):689-93. PubMed ID: 2560542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers.
    Grigoriadis A; Gazinska P; Pai T; Irhsad S; Wu Y; Millis R; Naidoo K; Owen J; Gillett CE; Tutt A; Coolen AC; Pinder SE
    J Pathol Clin Res; 2018 Jan; 4(1):39-54. PubMed ID: 29416876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of androgen receptors in breast cancer subtypes.
    Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
    Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
    Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
    BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
    Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
    PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitotic indexes as prognostic predictors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer.
    Chang CC; Tu HP; Chen YW; Lin CY; Hou MF
    J Int Med Res; 2014 Dec; 42(6):1209-21. PubMed ID: 25339454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].
    Meng HM; Yang YF; Qi LQ; Gu L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.